219 related articles for article (PubMed ID: 26802765)
21. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS
J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
O'Hanlon R; Grasso A; Roughton M; Moon JC; Clark S; Wage R; Webb J; Kulkarni M; Dawson D; Sulaibeekh L; Chandrasekaran B; Bucciarelli-Ducci C; Pasquale F; Cowie MR; McKenna WJ; Sheppard MN; Elliott PM; Pennell DJ; Prasad SK
J Am Coll Cardiol; 2010 Sep; 56(11):867-74. PubMed ID: 20688032
[TBL] [Abstract][Full Text] [Related]
23. Left ventricular apical aneurysm resection in hypertrophic cardiomyopathy.
Nguyen A; Pietras C; Schaff H
Multimed Man Cardiothorac Surg; 2018 Feb; 2018():. PubMed ID: 29485770
[TBL] [Abstract][Full Text] [Related]
24. Successful catheter ablation of hemodynamically unstable monomorphic ventricular tachycardia in a patient with hypertrophic cardiomyopathy and apical aneurysm.
Lim KK; Maron BJ; Knight BP
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):445-7. PubMed ID: 19054248
[TBL] [Abstract][Full Text] [Related]
25. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.
Francia P; Santini D; Musumeci B; Semprini L; Adduci C; Pagannone E; Proietti G; Volpe M; Autore C
J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1180-7. PubMed ID: 25066044
[TBL] [Abstract][Full Text] [Related]
26. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
[TBL] [Abstract][Full Text] [Related]
27. Refractory electrical storm in a patient with hypertrophic cardiomyopathy and an implantable cardioverter-defibrillator.
Nakayama H; Komatsu J; Nishimura Y; Sugane H; Hosoda H; Imai RI; Nakaoka Y; Nishida K; Mito S; Seki SI; Kubokawa SI; Fukatani M; Kawai K; Hamashige N; Doi Y
J Cardiol Cases; 2023 May; 27(5):233-236. PubMed ID: 37180214
[TBL] [Abstract][Full Text] [Related]
28. Apical hypertrophic cardiomyopathy with left ventricular apical aneurysm: Importance of multi-modality imaging.
Kherada N; Vinardell JM; Mihos CG; Santana O
Echocardiography; 2017 Sep; 34(9):1392-1395. PubMed ID: 28573739
[TBL] [Abstract][Full Text] [Related]
29. Left ventricular aneurysms in hypertrophic cardiomyopathy with midventricular obstruction: A systematic review of literature.
Elsheshtawy MO; Mahmoud AN; Abdelghany M; Suen IH; Sadiq A; Shani J
Pacing Clin Electrophysiol; 2018 Jul; 41(7):854-865. PubMed ID: 29786883
[TBL] [Abstract][Full Text] [Related]
30. Apical hypertrophic cardiomyopathy: prevalence and correlates of apical outpouching.
Binder J; Attenhofer Jost CH; Klarich KW; Connolly HM; Tajik AJ; Scott CG; Julsrud PR; Ehrsam JE; Bailey KR; Ommen SR
J Am Soc Echocardiogr; 2011 Jul; 24(7):775-81. PubMed ID: 21511435
[TBL] [Abstract][Full Text] [Related]
31. Apical aneurysm formation in apical hypertrophic cardiomyopathy: Pilot study with cardiac magnetic resonance.
Yang K; Yu SQ; Chen XY; Song YY; Yang SJ; Cui C; Zhao KK; Wei MD; Lu MJ; Zhao SH
Int J Cardiol; 2023 Jan; 371():480-485. PubMed ID: 36115439
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the prevalence, clinical features, and long-term outcomes of midventricular hypertrophy vs apical phenotype in patients with hypertrophic cardiomyopathy.
Cai C; Duan FJ; Yang YJ; Guo XY; Liu YL; Liu YQ; Yan LR; Xu ZM; Zhao SH; Hua W; Li YS; Fan CM
Can J Cardiol; 2014 Apr; 30(4):441-7. PubMed ID: 24468417
[TBL] [Abstract][Full Text] [Related]
33. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.
Biagini E; Coccolo F; Ferlito M; Perugini E; Rocchi G; Bacchi-Reggiani L; Lofiego C; Boriani G; Prandstraller D; Picchio FM; Branzi A; Rapezzi C
J Am Coll Cardiol; 2005 Oct; 46(8):1543-50. PubMed ID: 16226182
[TBL] [Abstract][Full Text] [Related]
34. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.
Prinz C; Schwarz M; Ilic I; Laser KT; Lehmann R; Prinz EM; Bitter T; Vogt J; van Buuren F; Bogunovic N; Horstkotte D; Faber L
Can J Cardiol; 2013 Mar; 29(3):358-63. PubMed ID: 22749647
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
[TBL] [Abstract][Full Text] [Related]
36. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
[TBL] [Abstract][Full Text] [Related]
37. Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy.
Coats CJ; Rantell K; Bartnik A; Patel A; Mist B; McKenna WJ; Elliott PM
Circ Heart Fail; 2015 Nov; 8(6):1022-31. PubMed ID: 26374874
[TBL] [Abstract][Full Text] [Related]
38. Clinical Characteristics and Long-Term Outcomes of Hypertrophic Cardiomyopathy.
Yoshinaga M; Yoshikawa D; Ishii H; Hirashiki A; Okumura T; Kubota A; Sakai S; Harada K; Somura F; Mizuno T; Fujiwara W; Yokoi H; Hayashi M; Ishii J; Ozaki Y; Murohara T; Yoshida Y; Amano T; Izawa H
Int Heart J; 2015; 56(4):415-20. PubMed ID: 26084460
[TBL] [Abstract][Full Text] [Related]
39. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
McLeod CJ; Ommen SR; Ackerman MJ; Weivoda PL; Shen WK; Dearani JA; Schaff HV; Tajik AJ; Gersh BJ
Eur Heart J; 2007 Nov; 28(21):2583-8. PubMed ID: 17483110
[TBL] [Abstract][Full Text] [Related]
40. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
